112 related articles for article (PubMed ID: 18452105)
1. Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly.
Viens D; St-Hilaire E; Beauregard P; Dufresne J; Knecht H
Leuk Lymphoma; 2008 Jul; 49(7):1424-6. PubMed ID: 18452105
[No Abstract] [Full Text] [Related]
2. Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
Carson DA; Piro LD; Wasson DB; Carrera CJ; Beutler E
Adv Exp Med Biol; 1989; 253A():427-31. PubMed ID: 2576181
[No Abstract] [Full Text] [Related]
3. 2-CdA in the treatment of hairy cell leukaemia.
Abhyankar D; Bajpai S; Saikia T; Gopal R; Nair CN; Advani SH
J Assoc Physicians India; 2001 Aug; 49():785-7. PubMed ID: 11837464
[TBL] [Abstract][Full Text] [Related]
4. Bilateral facial nerve palsy as first indication of relapsing hairy cell leukemia after 36 years.
Ferrari J; Lang W; Thurnher S; Müllauer L; Raderer M
Neurology; 2004 Jul; 63(2):399-400. PubMed ID: 15277655
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil for severe autoimmune haemolytic anemia.
Zimmer-Molsberger B; Knauf W; Thiel E
Lancet; 1997 Oct; 350(9083):1003-4. PubMed ID: 9329520
[No Abstract] [Full Text] [Related]
6. Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M
Cancer; 2010 Oct; 116(20):4788-92. PubMed ID: 20597132
[TBL] [Abstract][Full Text] [Related]
7. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
Lauria F; Rondelli D; Zinzani PL; Bocchia M; Marotta G; Salvucci M; Raspadori D; Ventura MA; Birtolo S; Forconi F; Tura S
Leukemia; 1997 May; 11(5):629-32. PubMed ID: 9180283
[TBL] [Abstract][Full Text] [Related]
8. [A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases].
Juliusson G; Liliemark J
Lakartidningen; 1991 Aug; 88(35):2746-9. PubMed ID: 1680209
[No Abstract] [Full Text] [Related]
9. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
[No Abstract] [Full Text] [Related]
10. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
Cheson BD
Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
[No Abstract] [Full Text] [Related]
11. Lymphoma, hairy-cell leukemia respond to new agents.
Oncology (Williston Park); 1992 Sep; 6(9):94. PubMed ID: 1449980
[No Abstract] [Full Text] [Related]
12. BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.
Zaja F; Di Loreto C; Amoroso V; Salmaso F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Mariuzzi L; Beltrami CA; Baccarani M
Leuk Lymphoma; 1998 Feb; 28(5-6):567-72. PubMed ID: 9613987
[TBL] [Abstract][Full Text] [Related]
13. Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenosine (2-CdA).
Virchis A; Mehta A
Br J Haematol; 1998 Mar; 100(3):609. PubMed ID: 9504654
[No Abstract] [Full Text] [Related]
14. The tumor necrosis factor family and and correlation with disease activity and response to treatment in hairy cell leukemia.
Barak V; Nisman B; Polliack A
Eur J Haematol; 1999 Feb; 62(2):71-5. PubMed ID: 10052708
[TBL] [Abstract][Full Text] [Related]
15. [2-CDA in treatment of hairy cell leukemia: a comparison between intravenous and subcutaneous administration. Swiss Study Group of Applied Cancer Research].
Sperb RA; von Rohr A; Ratschiller D; Bacchi M; Tichelli A; Hess U; Cerny T; Tobler A; Betticher DC
Schweiz Med Wochenschr; 1998 Oct; 128(42):1593-7. PubMed ID: 9824888
[TBL] [Abstract][Full Text] [Related]
16. 2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells.
Gora-Tybor J; Lech-Miranda E; Blonski JZ; Robak T
Adv Exp Med Biol; 2000; 486():307-10. PubMed ID: 11783506
[No Abstract] [Full Text] [Related]
17. Effective treatment of autoimmune hemolytic anemia and hairy cell leukemia with interferon-alpha.
Cesana C; Brando B; Boiani E; Chiodo F; Cairoli R; Intropido L; Morra E
Eur J Haematol; 2002 Feb; 68(2):120-1. PubMed ID: 11982619
[No Abstract] [Full Text] [Related]
18. Fulminant hepatitis C virus infection.
Schirmer M; Vogel W; Thaler J; Grünewald K; Umlauft F; Geisen F; Zilian U; Konwalinka G
Lancet; 1994 Jun; 343(8910):1433. PubMed ID: 7910911
[No Abstract] [Full Text] [Related]
19. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
Juliusson G; Liliemark J
Blood; 1992 Feb; 79(4):888-94. PubMed ID: 1346578
[TBL] [Abstract][Full Text] [Related]
20. The treatment of hairy cell leukemia: an update.
Golomb HM; Ratain MJ; Mick R; Daly K
Leukemia; 1992; 6 Suppl 2():24-7. PubMed ID: 1349662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
